Skip to content

CJC-1295 + Ipamorelin


CJC-1295 + Ipamorelin is a combination peptide protocol that pairs two complementary signaling peptides — a growth hormone–releasing hormone (GHRH) analog and a selective growth hormone secretagogue. Together, they are associated with supporting the body's natural pulsatile release of growth hormone, which is why this combination has become one of the most discussed protocols in conversations around vitality, recovery, body composition, and healthy aging.

CJC-1295 + Ipamorelin is frequently explored in discussions around lean body composition support, sleep quality, recovery, and overall regenerative care. It is one of the better-known peptide combinations in longevity and performance-focused conversations, valued for its targeted approach to growth hormone signaling.

This page is intended to support patient education and discussion. Any CJC-1295 + Ipamorelin–based protocol, if appropriate, is considered only after an in-person consultation and any necessary lab testing or clinical evaluation. Nothing on this page is intended to represent an online offer for sale, and these offerings are not available for online purchase. Nothing on this page constitutes medical advice, a prescription, or a guarantee of treatment.

EVOLVE CJC 1295 + Ipamorelin 10mg peptide vial from Evolve Anti-Aging & Wellness in Encino, CA
CJC-1295 + Ipamorelin Sale price$0.00
Woman in athletic wear walking through a sunlit Los Angeles patio with a gym bag and water bottle, illustrating the active wellness and recovery routine supported by CJC-1295 and Ipamorelin peptide therapy at Evolve Anti-Aging in Encino, CA
Man sitting poolside in athletic wear after a workout with a glass of water and CJC 1295 + Ipamorelin peptide vial, Los Angeles skyline in background, representing the vitality and recovery support associated with CJC-1295 and Ipamorelin peptide therapy at Evolve Anti-Aging & Wellness in Encino, CA

How It Works

CJC-1295 and Ipamorelin are two complementary signaling peptides that act on different receptors involved in the body's natural growth hormone release. CJC-1295 functions as a growth hormone–releasing hormone (GHRH) analog, while Ipamorelin selectively engages the ghrelin receptor pathway. Together, they are associated with supporting a more sustained and pulsatile pattern of growth hormone secretion that mirrors the body's natural rhythm.

Ipamorelin is considered a selective secretagogue, meaning it is associated with growth hormone signaling without the broader hormonal effects sometimes seen with other peptides in this category. CJC-1295 is associated with extending the natural amplitude of growth hormone pulses, which is why the two are often discussed together as a combination protocol.

Why People Are Interested

CJC-1295 + Ipamorelin has drawn significant interest because of its connection to vitality, recovery, body composition support, sleep quality, and healthy aging. It is often discussed in relation to lean body composition, post-workout recovery, restorative sleep, and broader longevity strategies.

Interest has also grown because natural growth hormone levels decline with age, which has made this combination increasingly relevant in conversations around age-related changes in energy, body composition, and overall resilience.

Benefits

CJC-1295 + Ipamorelin is being explored and discussed for its potential role in supporting:

- Growth hormone signaling
- Lean body composition support
- Recovery and post-exercise repair
- Sleep quality and restorative rest
- Energy and vitality
- Skin quality and collagen support
- Healthy aging and regenerative-care strategies
- Overall metabolic wellness

Who Can Benefit

CJC-1295 + Ipamorelin may be of interest to individuals exploring provider-guided support for healthy aging, body composition, recovery, sleep quality, and overall vitality. It is typically considered within the context of a broader evaluation rather than as a one-size-fits-all solution.

The right approach depends on the individual, their goals, health history, and any relevant clinical findings, including hormone-related markers when appropriate.

Why Evaluation Matters

At Evolve, treatment decisions are guided by more than interest in a peptide alone. A consultation helps determine whether CJC-1295 + Ipamorelin is appropriate based on the full clinical picture, including current concerns, recovery and vitality goals, health history, and when necessary, lab testing or additional hormone-related evaluation.

This process supports a more personalized plan and helps ensure that any recommendation fits into a broader strategy for healthy aging, recovery, and long-term optimization.

Treatment Process

The process begins with an in-person consultation at Evolve Anti-Aging & Wellness in Encino, CA to review health history, current concerns, vitality and recovery goals, and any relevant clinical considerations. When appropriate, further evaluation including hormone-related lab testing may be used to better understand the broader picture and determine fit.

If CJC-1295 + Ipamorelin is considered appropriate, it is discussed as part of a personalized, provider-guided plan designed around healthy aging, regenerative support, and ongoing optimization.

Every program at Evolve follows a structured clinical model:

Schedule a Peptide Consultation

Discuss whether this approach may be appropriate as part of your personalized care plan.